WithdrawnPhase 4NCT01903057

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Studying Filariasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emory University
Principal Investigator: Huub C Gelderblom, MD, PhD, MPH
Emory University
Intervention: azithromycin(drug)
Eligibility: 5-65 years · All sexes
Timeline: 2014 – 2014

Study locations (1)

National Institute of Health, Ministry of Health, Maputo, Cidade de Maputo, Mozambique

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01903057 on ClinicalTrials.gov

Other trials for Filariasis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001230
Host Response to Infection and Treatment in Filarial Diseases
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Filariasis →

← Back to all trials